Skip to content
Emerging Research

DSIP

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) discovered in 1974 in rabbit brain.

Also known as: Delta Sleep-Inducing Peptide, Sleep & Stress Modulator

Typical Dose 100-200mcg
Storage Refrigerate reconstituted; store lyophilized powder away from light
How Often Once nightly

Overview

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) discovered in 1974 in rabbit brain. Originally isolated for its sleep-promoting properties, DSIP has since been found to have diverse neuromodulatory effects including stress reduction, pain modulation, and endocrine regulation, though its exact mechanisms and clinical efficacy remain subjects of ongoing research.

Key Benefits

  • Deep Sleep Enhancement
  • Sleep Efficiency
  • Natural Sleep Architecture

Enhanced sleep quality through slow-wave sleep promotion, stress reduction via cortisol modulation, potential pain relief, and mood stabilization without traditional sedative effects.

Mechanism of Action

Modulates multiple neurotransmitter systems including GABA enhancement, NMDA receptor interaction, and endogenous opioid system modulation. Also regulates hypothalamic-pituitary-adrenal axis.

Pharmacokinetics

Peak plasma concentration: 30 min. Elimination half-life: 8 min. Largely cleared by: ~39 min.

Research Protocols Injectable

GoalDoseFrequencyRoute
Sleep Enhancement100-200mcgOnce nightlySubcutaneous
Chronic Pain250-300mcgDailySubcutaneous
Stress Management150mcgEveningSubcutaneous
Withdrawal Support200-300mcgTwice dailySubcutaneous
Athletic Recovery100-150mcgPost-trainingSubcutaneous

Research protocols from published literature — not dosing recommendations.

Peptide Interactions

  • Melatonin — Synergistic: Both regulate sleep-wake cycles - DSIP enhances slow-wave sleep while melatonin regulates circadian rhythm, creating complementary sleep benefits
  • GABA Agonists — Monitor Combination: DSIP enhances GABA activity - monitor for excessive sedation when combining with benzodiazepines or other GABA modulators
  • Cortisol Modulators — Compatible: DSIP helps regulate cortisol - can be used alongside adaptogenic compounds for comprehensive stress management
  • Selank — Synergistic: Complementary anxiolytic effects - Selank reduces anxiety while DSIP improves sleep and stress response
  • Semax — Compatible: Different mechanisms - Semax for daytime cognition, DSIP for nighttime recovery, creating 24-hour optimization
  • Opioid Medications — Use Caution: DSIP may modulate opioid receptors and has been used in withdrawal - professional supervision required with opioid medications
  • Growth Hormone Peptides — Compatible: No direct interaction - DSIP may support natural GH release during sleep without interfering with GH peptides
  • Epitalon — Synergistic: Both support circadian regulation - Epitalon enhances melatonin production while DSIP improves sleep quality

Peptide Instructions Injectable

Supplies:

  • DSIP peptide vial (1-5mg typical)
  • Bacteriostatic water (1-2ml)
  • Insulin syringes (0.3-0.5ml)
  • Alcohol swabs
  • Sterile needle for mixing

How to Reconstitute Injectable

  1. 1Clean vial tops with alcohol swab and let dry completely
  2. 2For 1mg vial, add 1ml BAC water (creates 1mg/ml or 1000mcg/ml)
  3. 3Inject water slowly down vial side to prevent foaming
  4. 4Gently roll between palms - do not shake
  5. 5Solution should be clear and colorless
  6. 6For 100mcg dose, draw 0.1ml (10 units on insulin syringe)
  7. 7Store reconstituted peptide in refrigerator immediately

What to Expect Injectable

First dose: Noticeable sleep pressure and easier sleep onset. Night 1-3: Deeper sleep, fewer awakenings, vivid dreams possible. Day 2-5: Improved morning refreshment, stable daytime energy. Day 5-10: Cumulative stress reduction, mood improvements. Post-cycle: Benefits may persist 1-2 weeks after stopping.

Side Effects & Safety

Generally well-tolerated with minimal side effects. Some users report mild drowsiness or dizziness initially. Occasional reports of headaches in sensitive individuals. No tolerance or dependence reported in studies. Avoid driving until effects are known. Not recommended during pregnancy or breastfeeding.

Generally well-tolerated with minimal side effects. Some users report mild drowsiness or dizziness initially. Occasional reports of headaches in sensitive individuals. No tolerance or dependence reported in studies. Avoid driving until effects are known. Not recommended during pregnancy or breastfeeding.

Community Insights

DSIP should be stored at Refrigerate at 2-8°C, protect from light, use within 14 days.

Molecular Information

Molecular Weight 848.81 Da
Length 9
Type Neuropeptide
Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

References

  1. Stroke Recovery in Rats (2021) · 2021
  2. Chronic Insomnia Double-Blind Study (1991) · 1991
  3. Endocrine Modulation Research (1988) · 1988
  4. Chronic Pain Pilot Study (1984) · 1984
  5. Alcohol and Opioid Withdrawal (1984) · 1984
  6. Sleep Pressure Induction Study (1983) · 1983

Research reference only. Not medical advice.